Skip to main content
. Author manuscript; available in PMC: 2017 Mar 30.
Published in final edited form as: J Neurooncol. 2016 Feb 27;128(1):57–66. doi: 10.1007/s11060-016-2073-5

Fig. 2.

Fig. 2

a Expression of asparagine synthetase (ASNS), glutaminase (GLS), and branched chain aminotransferases (BCAT1) in anaplastic gliomas (AG) versus glioblastomas (GBM), and expression of ASNS in newly diagnosed versus recurrent GBMs. GBMs have higher expression of all of these genes, compared to AGs. Recurrent GBMs have higher ASNS expression, compared to newly diagnosed GBMs. *P values (t test) are significant. b Asparagine synthetase (ASNS), glutaminase (GLS), and BCAT1, branched chain amino-acid aminotransferase expression in paired samples obtained from individual patients. ASNS expression was increased in 4 recurrences. GLS expression was increased in 3 recurrences. The horizontal axis indicates the diagnoses at dual surgeries, for each patient. AO, anaplastic oligodendroglioma; AMG, anaplastic mixed glioma, GBM, glioblastoma